HIF1A and osteosarcoma: In this work we show for the first time that osteosarcoma cells are resistant to the clinically relevant cytotoxics cisplatin, doxorubicin and etoposide in hypoxia and that this resistance is not dependent on HIF-1, or on an active PI3K pathway, suggesting the need to investigate other hypoxia-related targets in this tumour type.